Indian Journal of Medical Microbiology Home 

KEYNOTE ADDRESS
[Download PDF]
Year : 2019  |  Volume : 37  |  Issue : 5  |  Page : 1-

Invited Speakers

Roberto Bruzzone 
 HKU-Pasteur Research Pole, The University of Hong Kong, Hong Kong SAR

Correspondence Address:

How to cite this article:
Bruzzone R. Invited Speakers.Indian J Med Microbiol 2019;37:1-1

How to cite this URL:
Bruzzone R. Invited Speakers. Indian J Med Microbiol [serial online] 2019 [cited 2020 Mar 29 ];37:1-1
Available from: http://www.ijmm.org/text.asp?2019/37/5/1/259322

Full Text



 Keynote Address



 New Frontiers in the Study of Emerging and Re-emerging Infectious Diseases



Roberto Bruzzone

HKU-Pasteur Research Pole, The University of Hong Kong, Hong Kong SAR

Recent epidemics (avian and H1N1 influenza, chikungunya, MERS coronavirus, Ebola, Zika virus etc.) have underscored not only the growing globalization of health issues, but also the evolving interrelationships among human health, animal health and our ecosystems. It is estimated that 60% of infectious diseases are of animal origin and that 75% of emerging infectious diseases are zoonoses. Climate change, deforestation, uncontrolled urbanization, and changes in farming methods have encouraged the interspecies transmission of pathogens and have deeply modified the impact of the environment on our health. This changing international landscape, of increased coordination, collaboration and investment, requires an equal response from the international clinical research community. It is time to adopt a new integrative approach, combining the fields of animal and human health, to generate the evidence to improve clinical care and public health responses, and to support the development and evaluation of new diagnostics, drugs and vaccines. I will discuss how major international networks, such as the Institute Pasteur International Network (IPIN) and International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) are tackling emerging, remerging, and “traditional” infectious diseases, which remain a clear and present threat to health and equity for which we are not adequately prepared. The shared goals are to reduce the risk and impact of epidemics requires a stable, agile, and proficient network of research partners. The role of local investigators and research networks is therefore more critical than ever. This strategy defines the role that IPIN and ISARIC aspire to have, by its members and for its members